Table 1 Patient and disease characteristics at baseline.
Patients (n = 41) | |
|---|---|
Sex, n (%) | |
Female | 22 (54%) |
Male | 19 (46%) |
Age, median (range), years | 62 (43–81) |
Tumour types, n (%) | |
Colorectal | 27 (66%) |
Non-small-cell lung cancer | 11 (27%) |
Pancreatic | 3 (7%) |
ECOG PS, n (%) | |
0 | 16 (39%) |
1 | 25 (61%) |
Number of prior lines of therapy, n (%) | |
0 | 1 (2%) |
1 | 7 (17%) |
2 | 13 (32%) |
≥3 | 20 (49%) |
KRAS mutation, n (%) | |
Exon 2 | 36 (88%) |
Exon 3 | 3 (7%) |
Exon 4 | 2 (5%) |
